Surgical Treatment of Total Anomalous Pulmonary Venous Drainage with Atrial Fibrillation in an Adult: A Case Report and Literature Review

Authors

  • Jun Xiang Department of Cardiac Macrovascular Surgery, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, P.R. China
  • Shuliang Wei Department of Cardiac Macrovascular Surgery, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, P.R. China

DOI:

https://doi.org/10.1532/hsf.4313

Keywords:

total anomalous pulmonary venous drainage; atrial fibrillation; radiofrequency ablation

Abstract

Total anomalous pulmonary venous drainage (TAPVD) is caused by the absence of the congenital connection between the pulmonary vein and left atrium. This causes blood drainage into the right atrium, resulting in poor development of the left atrium and increasing the burden for the right atrium. It is accompanied by an atrial septal defect. TAPVD mostly is diagnosed during the fetal period and rarely is reported in adults. Atrial fibrillation (AF), a common arrhythmia, originates primarily from the joint of the pulmonary vein and left atrium, whereas AF originating from the right atrium has not been documented. Herein, we report the case of a 45-year-old male diagnosed with TAPVD accompanied by AF. After the correction of TAPVD and radiofrequency ablation (RFA) for AF performed under general anesthesia and cardiopulmonary bypass, the patient returned to normal sinus rhythm and showed no AF recurrence during two years of follow up.

References

Byounghyun L, Je-Wook P, Hwang M, et al. 2020. Electrophysiological significance of the interatrial conduction including cavo-tricuspid isthmus during atrial fibrillation. 598: 3597-3612.

Czekajska-Chehab E, Tomaszewski A, Adamczyk P, et al. 2018. Total anomalous pulmonary vein drainage in a 60-year-old woman diagnosed in an ECG-gated multidetector computed tomography - a case report and review of literature. Pol J Radiol. 83: e334-e339.

Ehrlich MP, Osorio-Jaramillo E, Aref T, et al. 2020. Atrial fibrillation after cardiac surgery: electrophysiological mechanism and outcome [J]. Ann Thorac Surg. 109(6):1765-1772.

Fukamizu S, Sakurada H, Nishizaki M, et al. 2012. Catheter ablation in a patient with partial anomalous pulmonary venous return and atrial fibrillation [J]. Heart Rhythm. 9(6):1002-1003.

Hołda Jakub, Słodowska Katarzyna, Tyrak Kamil, et al. 2020. Topographical anatomy of the right atrial appendage vestibule and its isthmuses [J]. J Physiol. 598(17):3597-3612.

Hossein S, Ahmad T. 2019. A new palliative surgical technique for high risk total anomalous pulmonary venous connection (Sarmast-Takriti shunt). J Cardiothorac Surg. 14(1): 127.

Hugh C. 2020. Important differences exist between atrial fibrillation and atrial flutter in atrial remodeling[J]. J Am Coll Cardiol. 76(4):389-390.

Jean-Baptiste G, Patrice N, Feng X, et al. 2020. Comparison of atrial remodeling caused by sustained atrial flutter versus atrial fibrillation [J] J Am Coll Cardiol. 76(4):374-388.

Lau DH, Linz D, Sanders P. 2019. New findings in atrial fibrillation mechanisms[J]. Card Electrophysiol Clin. 11(4):563-571.

Poynter JA, Beckman DJ, Abarbanell AM, et al. 2010. Surgical treatment of atrial fibrillation: the time is now[J] Ann Thorac Surg. 90(6):2079-2086.

Seungyup L, Celeen MK, Jayakumar S, et al. 2020. Reconsidering the multiple wavelet hypothesis of atrial fibrillation.[J]. Heart Rhythm. 22:S1547-5271(20)30595-6.

Yanqiang Z, Jie W, Guohua W, et al. 2019. Infracardiac total anomalous pulmonary venous return in a patient with Williams syndrome: A case report. Medicine (Baltimore). 98(26):e16276.

Yong MS, Yaftian N, Weintraub RG, et al. 2017. Outcomes of surgery for mixed total anomalous pulmonary venous drainage in children. Semin Thorac Cardiovasc Surg. 29(3):338-344.

Yong MS, Zhu MZL, du Plessis K, et al. 2019. Long-term outcomes of the Fontan operation in patients with total anomalous pulmonary venous drainage. Ann Thorac Surg. 108(4):1234-1241.

Yong MS, Zhu MZL, Huang L, et al. 2020. Long-term quality of life outcomes in adult survivors after anomalous pulmonary venous drainage repair. Ann Thora Surg. 110(2):654-659.

Published

2022-01-18

How to Cite

xiang, jun, & Wei, S. (2022). Surgical Treatment of Total Anomalous Pulmonary Venous Drainage with Atrial Fibrillation in an Adult: A Case Report and Literature Review. The Heart Surgery Forum, 25(1), E065-E068. https://doi.org/10.1532/hsf.4313

Issue

Vol. 25 No. 1 (2022)

Section

Articles

Author Disclosure & Copyright Transfer Agreement

In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.

A current form follows:

The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.

However, Publisher grants back to the author(s) the following:

  1. The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
  2. The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
  3. The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
  4. The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
  5. The right to make oral presentations of material from this work.

Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.

I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.

I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).

I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.

Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).